Full Length Research Paper
References
|
Akinsola A, Olusanya O, Iyun AO, Mbanefo CO (1984). Role of hepatitis Bs antigen in chronic glomerulonephritides in Nigerians. Africa Journal of Medicine and Medical Science 13:33‑39. |
|
|
Alashek WA, McIntyre CW, Taal MW (2012). Hepatitis B and C infection in haemodialysis patients in Libya: prevalence, incidence and risk factors. BMC Infect Disease 12:265. |
|
|
Amira CO, Lesi OA (2017). Seroprevalence of hepatitis B and C infection among Nigerian subjects with chronic kidney disease. Journal Clinical Science 14:58-61. |
|
|
Assarehzadegan MA, Shakerinejad G, Noroozkohnejad R, Amini A, Rahim Rezaee SA (2009). Prevalence of hepatitis C and B infection and HCV genotypes among hemodialysis patients in Khuzestan province, southwest Iran. Saudi Journal of Kidney Disease and Transplanting 20:681-684. |
|
|
Ayodele OE, Salako BL, Kadiri S, Arije A, Alebiosu CO (2006). Hepatitis B virus infection: Implications in chronic kidney disease, dialysis and transplantation. Africa Journal of Medicine Medical Science 35:111‑119. |
|
|
Bahri F, Kheirabad AK, Ghasemzadeh I, Shoja S, Gouklani H (2016). Hepatitis Viruses B and D and Human Immunodeficiency Virus Infections in Hemodialysis Patients in the South of Iran: Prevalence and Genotypes. Hepatology Mon. 16(1):e32971 |
|
|
Bernieh B (2015). Viral hepatitis in hemodialysis: an update. Journal of Translational Internal Medicine 3(3):93-105. |
|
|
Bhimma R, Coovadia HM, Adhilari M (1998). Hepatitis B virus‑associated nephropathy membranous nephropathy in black South African children. Pediatrician Nephrology 11:429‑34. |
|
|
Burdick RA, Bragg-Gresham JL, Woods JD, Hedderwick SA, Kurokawa K, Combe C, Saito A, LaBrecque J, Port FK, Young EW (2003). Patterns of hepatitis B prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney International 63(6):2222-2229. |
|
|
Daw MA, Elkaber MA, Drah AM, Werfalli MM, Mihat AA, Siala IM (2002). Prevalence of hepatitis C virus antibodies among different populations of relative and attributable risk. Saudi Medical Journal 23(11):1356-1360. |
|
|
Edey M, Barraclough K, Johnson DW (2010). Review article: Hepatitis B and dialysis. Nephrology (Carlton) 15:137-45. |
|
|
Fabrizi F, Poordad F, Martin P (2002). Hepatitis C. Infection and the patients with end-stage renal disease. Hepatology 36(1):3-10. |
|
|
Fabrizi F, Verdesca S, Messa P, Martin P (2015). Hepatitis C virus infection increases the risk of developing chronic kidney disease: a systematic review and meta-analysis. Dig Disease Science 60(12):3801-3813. |
|
|
Fabrizi F (2013). Hepatitis C virus infection and dialysis: 2012 update. ISRN nephrology 159760. |
|
|
Garima M, Gupta P, Thakuriaz B, Mukhiyax GK, Mittaly M (2013). Profile of Hepatitis B Virus, Hepatitis C Virus, Hepatitis D Virus and Human Immunodeficiency Virus Infections in Hemodialysis Patients of a Tertiary Care Hospital in Uttarakhand. Journal Clinical Experimental Hepatology 3:24-28 |
|
|
Halle MP, Choukem SP, Kaze FF, Ashuntantang G, Tchamago V (2016). Hepatitis B, Hepatitis C and Human immune deficiency virus seroconversion positivity rates and their potential risk factors among patients on maintenance hemodialysis in Cameroon. Iranian Journal of Kidney Diseases 10(5):304-309. |
|
|
Jadoul M, Martin P (2017). Hepatitis C Treatment in Chronic Kidney Disease Patients: The Kidney Disease Improving Global Outcomes Perspective. Blood Purification 43:206-209. |
|
|
Jibrin B, Jiya NM, Ahmed H (2014). Seroprevalence of hepatitis C virus antibody and its associated risk factors in children with sickle cell anaemia. Sub-Saharan Africa Journal of Medicine 1:20-25. |
|
|
Lesi OA, Kehinde MO (2003). Hepatitis C virus infection in patients with sickle cell anaemia at the Lagos University Hospital. Niger Postgraduate Medical Journal 10:79‑83. |
|
|
Luma HN, Halle MP, Eloumou SAF, Azingala F, Kamdem F, Donfack-Sontsa O, Ashuntantang G (2017). Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses among haemodialysis patients in two newly opened centres in Cameroon. |
|
|
Musa B, Bussell S, Borodo MM, Samaila AA, Femi OL (2015). Prevalence of hepatitis B virus infection in Nigeria, 2000-2013: A systematic review and meta-analysis. Niger Journal Clinical Practice 18:163-167. |
|
|
Rinonce HT, Yano Y, Utsumi T, Heriyanto DS, Anggorowati N, Widasari DI (2013). Hepatitis B and C virus infection among hemodialysis patients in Yogyakarta, Indonesia: Prevalence and molecular evidence for nosocomial transmission. Journal of Medicine and Virology 85:1348‑61. |
|
|
Suliman AM, Busaobiuah J, Al-Baqshi M, Qadiaub K, Bushrah M, Homrany H, Aljassam A, Khan SA (2013). Prevalence of hepatitis B and C in adult sickle cell disease patients in the eastern province of Saudi Arabia. Journal Applied Hematology 4:33-35 |
|
|
Ulasi II, Ijoma CK (2010). The enormity of chronic kidney disease in Nigeria: the situation in a teaching hospital in south-east Nigeria. Journal of Tropical Medicine pp. 1-6. |
|
|
World Health Organization (2017). Hepatitis Global hepatitis report, |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
